Docket Number:28A-1040415
Inventor:Tse-Wen Chang, Alfur Fu-Hsin HUNG, Donic Chien-Sheng LU
IP Status:CN 106029092 B、JP 6316966、TW I603979、US 9688776
Abstract:
The technology is an anti-migis-α antibody specific for the migis-α of human mα chain that can bind to mIgA on B lymphocytes, cause the lysis of mIgA-expressing B lymphocytes, and decrease IgA production by IgA-secreting B lymphocytes.
Fields of Application:
IgA nephropathy
Advantages when compared to the existing technologies:
The technology can benefit from the elimination of mIgA-expressing cells or the reduction of IgA antibodies in the immune system.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
